Re-adenylation by TENT5A enhances efficacy of SARS-CoV-2 mRNA vaccines
- Home
- Resource Centre
- Re-adenylation by TENT5A enhances efficacy of SARS-CoV-2 mRNA vaccines
Using direct RNA Oxford Nanopore sequencing, researchers uncovered a novel mechanism enhancing mRNA vaccine performance: re-adenylation by TENT5A. This enzyme extends mRNA poly-A tails to boost mRNA stability and antigen production. This study showcases how nanopore sequencing enables real-time, single-molecule insights into mRNA metabolism — offering a strategy to improve future RNA-based therapeutics.